Deborah R Kaye, MD, MS
Affiliations: | 2009-2010 | National Cancer Institute, Rockville, MD, United States | |
| 2018- | Urology | Duke University Medical School, Durham, NC, United States |
Google:
"Deborah Kaye"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Kaye DR, Lee HJ, Gordee A, et al. (2024) Systemic treatments for advanced prostate cancer: relationship between health insurance plan and treatment costs. The American Journal of Managed Care. 30: e274-e281 |
| Kaye DR, Tu K, Davis JK, et al. (2024) Physician Perspectives on the Nonclinical Factors That Contribute to Decision-Making for Advanced Prostate Cancer Care: A Qualitative Study. Ju Open Plus. 2 |
| Kurnot JA, Kaye DR. (2024) Reducing financial toxicity in bladder cancer care. Current Opinion in Urology |
| Kaye DR, Khilfeh I, Muser E, et al. (2024) Real-world economic burden associated with disease progression from metastatic castration-sensitive to castration-resistant prostate cancer on treatment in the United States. Journal of Managed Care & Specialty Pharmacy. 30: 684-697 |
| Kaye DR, Khilfeh I, Muser E, et al. (2024) Characterizing the real-world economic burden of metastatic castration-sensitive prostate cancer in the United States. Journal of Medical Economics. 27: 381-391 |
| Kaye DR, Khilfeh I, Muser E, et al. (2024) Real-world economic burden of metastatic castration-resistant prostate cancer before and after first-line therapy initiation. Journal of Medical Economics. 1-39 |
| Moses KA, Sprenkle PC, Bahler C, et al. (2023) NCCN GuidelinesĀ® Insights: Prostate Cancer Early Detection, Version 1.2023. Journal of the National Comprehensive Cancer Network : Jnccn. 21: 236-246 |
| Kaye DR, Lee HJ, Gordee A, et al. (2023) Medication Payments by Insurers and Patients for the Treatment of Metastatic Castrate-Resistant Prostate Cancer. Jco Oncology Practice. OP2200645 |
| Wilcox Vanden Berg RN, George AK, Kaye DR. (2022) Should Transperineal Prostate Biopsy Be the Standard of Care? Current Urology Reports |
| Sessine MS, Das S, Park B, et al. (2021) Initial Findings from a High Genetic Risk Prostate Cancer Clinic. Urology |